Register for our free email digests:
Latest From Nohla Therapeutics Inc.
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Newly renamed Flagship Pioneering has raised a $285m venture capital fund to remain invested in portfolio companies as they grow. Also, 12 new and growing biopharma companies raised $657.15m.
The firm’s $260m Series D is the largest ever for biopharma in China and one of the biggest of the year worldwide; other notable financings go to Biohaven, Kymab and Magenta. Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmaceutical companies that have received venture funding. This month’s column covers deals announced October through early December.
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Senior Management
Richard Mueller, CEO
William Gacki, CFO
Myra Patchen, PhD, CSO
Donald Cox, PhD, SVP, R&D & Bus. Dev.
Jose Iglesias, MD, CMO
- Contact Info
Phone: (651) 675-0300
3388 Mike Collins Dr.
Eagan, MN 55121
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.